The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis

F. Barkhof, R. Jong, N. Sfikas, A. de Vera, G. Francis, J. Cohen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1704-1713
JournalMultiple Sclerosis
Volume20
Issue number13
DOIs
Publication statusPublished - 2014

Cite this

@article{db4894f5685843efa9e505bd176176d9,
title = "The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis",
author = "F. Barkhof and R. Jong and N. Sfikas and {de Vera}, A. and G. Francis and J. Cohen",
year = "2014",
doi = "10.1177/1352458514532317",
language = "Undefined/Unknown",
volume = "20",
pages = "1704--1713",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "13",

}

TY - JOUR

T1 - The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis

AU - Barkhof, F.

AU - Jong, R.

AU - Sfikas, N.

AU - de Vera, A.

AU - Francis, G.

AU - Cohen, J.

PY - 2014

Y1 - 2014

U2 - 10.1177/1352458514532317

DO - 10.1177/1352458514532317

M3 - Article

VL - 20

SP - 1704

EP - 1713

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 13

ER -